ClinicalTrials.gg
Not yet recruitingNCT07947784ECPON IIUpdated Nov 19, 2026

Enhancing Cognitive and Postoperative Recovery After Cardiac Surgery in Older Adults (ECPON II)

An interventional study of ECPON II Nurse Navigator-led Intervention in Cardiac Surgical Procedures, Cognition and Cognitive Dysfunction, Postoperative, sponsored by Karolinska Institutet. Not yet recruiting at 1 site in Sweden. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Supportive care

How we know

Updated Nov 19, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Study summary

Postoperative cognitive complaints are common among older adults undergoing cardiac surgery and may negatively affect recovery, daily functioning, independence, and quality of life. The ECPON II study evaluates the effectiveness of a co-designed, nurse navigator-led intervention designed to support cognitive and postoperative recovery in older adults undergoing cardiac surgery.

Fifty patients aged 65 years or older undergoing cardiac surgery will receive the intervention. Outcomes will be compared with data from 150 matched historical controls from the previous ECPON observational study (ECPON I; NCT06469515). The historical controls are not enrolled in ECPON II.

The intervention consists of four coordinated components: information and education, postoperative consultations, cognitive assessments, and peer support, coordinated and delivered by a nurse navigator. The primary outcome is patient-reported cognitive complaints. Secondary outcomes include postoperative recovery, cognitive function, delirium, frailty, depression, health-related quality of life, functional capacity, self-efficacy, caregiver burden, and cost-utility. Participants will be followed for six months after surgery.

Read the detailed description

Postoperative neurocognitive impairment and cognitive complaints are important complications following cardiac surgery in older adults. Cognitive complaints may include difficulties with memory and concentration, fatigue, sleep disturbances, and reduced ability to manage everyday activities. These problems may influence postoperative recovery, independence, rehabilitation, and quality of life and may also affect close relatives.

ECPON II is a quasi-experimental superiority study evaluating a co-designed intervention coordinated and delivered by a nurse navigator. The intervention was developed through an experience-based co-design process involving older adults who had undergone surgery, close relatives, healthcare professionals, and scientific experts.

The intervention comprises four core components: (1) information and education regarding postoperative cognitive difficulties and strategies for managing them; (2) individualized postoperative consultations with a nurse navigator; (3) cognitive assessments before and after surgery to identify and follow cognitive difficulties and support individualized postoperative care; and (4) peer-support sessions for patients and close relatives.

Fifty patients aged 65 years or older undergoing open cardiac surgery will be prospectively enrolled and receive the intervention. Each patient will be asked to nominate a close relative who will be invited to participate in selected study activities. Close relatives will provide assessments of the patient's cognitive functioning and caregiver burden and may participate in peer-support sessions and qualitative interviews. If the patient has no close relative or the nominated person declines participation, the patient remains eligible for the study.

Outcomes in the intervention group will be compared with data from 150 matched historical controls from ECPON I (NCT06469515), an observational study conducted in the same patient population. The historical controls are used as comparator data and are not included in the ECPON II enrollment.

The primary objective is to determine whether the intervention reduces patient-reported cognitive complaints following cardiac surgery. Secondary objectives include evaluating postoperative recovery, cognitive function, self-efficacy, functional status, fatigue, depression, frailty, health-related quality of life, caregiver burden, and cost-utility.

A purposive sample of approximately 20-40 patients and their close relatives will participate in semi-structured individual interviews six months after surgery to explore experiences of the intervention, mechanisms of impact, feasibility, postoperative cognition, and recovery. In addition, all patients will be asked about any experience with postoperative delirium and, if so, to describe any long-term experiences as well as overall experience of postoperative cognition and its impact on recovery.

02

Conditions studied

  • Cardiac Surgical Procedures
  • Cognition
  • Cognitive Dysfunction, Postoperative
  • Postoperative Complications
  • Aged
  • Patient-Centered Care

Keywords

  • Aged, Cardiac Surgical Procedures, Cognition, Cognitive Dysfunction, Patient-Centered Care, Postoperative Complications, Postoperative Complications
03

In context

Postoperative Cognitive Complications

260 studies on the registry are indexed under Postoperative Cognitive Complications; 55 are open to participants now.

This study's planned enrollment of 50 is below the median of 107 across 145 interventional studies indexed under Postoperative Cognitive Complications.

Browse Postoperative Cognitive Complications studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,150 studies on the registry; 277 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Scheduled for elective or urgent open-heart surgery or minimally invasive cardiac surgery
  • Resident in the area/region for the current thoracic clinic
  • Able to read and understand Swedish

Exclusion criteria

Exclusion Criteria:

  • Physical, mental, and cognitive difficulties that prevent the individual from completing the cognitive tests
  • Undergone surgery within the last 6 months
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    ECPON II Nurse Navigator-led Intervention

    Behavioral: ECPON II Nurse Navigator-led Intervention

Interventions

  • BehavioralECPON II Nurse Navigator-led Intervention

    The intervention comprises four coordinated components: 1. Information and education: Verbal and written information about cognitive difficulties after cardiac surgery, their impact on daily life and recovery, and strategies for managing them. 2. Postoperative consultations: An individual consultation with the nurse navigator 2-3 weeks after discharge, addressing recovery, challenges, support, and self-management. A person-centred care plan is developed, with additional consultations as needed. 3. Cognitive assessment: Cognitive function, cognitive complaints, daily functioning, and recovery are assessed before and after surgery to guide individualized support. 4. Peer support: Small-group sessions for patients and close relatives, facilitated by the nurse navigator, focus on shared experiences, self-management, and recovery.

06

What researchers measure

Primary outcomes

  1. Patient-reported cognitive complaints

    Patient-reported cognitive complaints will be assessed using the Cognitive Recovery dimension of the Swedish Quality of Recovery-Cognitive (SwQoR-Cog). The dimension comprises 10 items assessing symptoms related to cognitive complaints, including fatigue, sleep difficulties, concentration difficulties, frustration, forgetfulness, difficulties reading or calculating, and reduced ability to function independently. Each symptom is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden.

    Time frame: Preoperatively and weekly from 3-5 days after discharge through 6 months after surgery.

Secondary outcomes

  1. Postoperative recovery

    Evaluated with the General recovery dimension of the SwQoR-Cog, consisting of 4 items measuring symptoms related to pain, nausea, the wound, and difficulties with personal hygiene. Each item is rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time"), with higher scores indicating a greater symptom burden.

    Time frame: Preoperatively and weekly through 6 months

  2. Nightmares

    Patient-reported frequency/severity of nightmares rated on an 11-point numerical rating scale ranging from 0 ("none of the time") to 10 ("all of the time").

    Time frame: Weekly through 6 months

  3. Cognitive function

    Consortium to Establish a Registry for Alzheimer's Disease (CERAD). The CERAD measures verbal learning and memory performance. Participants are presented with a list of 10 words across three learning trials and asked to recall as many words as possible after each trail.

    Time frame: Preoperatively, 1 month, 3 months and 6 months

  4. Executive functioning

    Stroop Colour-Word Interference Test (SCWT) is used to assess executive functioning, selective attention, and inhibitory control. In this timed test, participants are required to identify the colour of words printed in incongruent colours as quickly and accurately as possible

    Time frame: Preoperatively, 1 month, 3 months and 6 months

  5. Postoperative delirium

    Nursing Delirium Screening Scale (Nu-DESC). The scale assesses five symptom domains associated with delirium, with higher scores reflecting greater symptom severity. A total score of 2 or above is considered indicative of delirium.

    Time frame: Three times daily during hospitalization

  6. Frailty

    Clinical Frailty Scale (CFS), a nine-point instrument that classifies individuals from very fit to terminally ill. Assessments are conducted by trained clinicians based on the individual's pre-illness functional status.

    Time frame: Preoperatively and 6 months

  7. Depressive symptoms

    Patient Health Questionnaire-9 (PHQ-9), nine items assessing depressive symptoms experienced during the preceding two weeks, with response options ranging from 0 ("not at all") to 3 ("nearly every day").

    Time frame: Preoperatively, 1 month, 3 months and 6 months

  8. Health-related quality of life

    RAND-36 questionnaire encompassing eight dimensions of health: physical functioning, physical role limitations, emotional role limitations, vitality, mental health, social functioning, pain, and general health. Domain scores as well as physical and mental summary scores will be calculated to provide an overall assessment of health status.

    Time frame: Preoperatively and 6 months

  9. Functional capacity

    World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0), 12-item version. This instrument evaluates difficulties in performing everyday activities and participating in daily life in relation to an individual's current health status. Each item is rated on a five-point scale reflecting the degree of difficulty experienced, generating a total score ranging from 0 to 48. Higher scores indicate greater disability and functional limitations

    Time frame: Preoperatively, 1 month, 3 months and 6 months

  10. Self-efficacy

    General Self-Efficacy Scale (GSE), 10 items assessing an individual's perceived ability to handle demanding situations and solve problems effectively. Items are rated on a four-point scale, and higher scores reflect greater self-efficacy.

    Time frame: Preoperatively, 1 month, 3 months and 6 months

  11. Cognitive functioning assessed by close relatives

    Cognitive Failures Questionnaire for Others (CFQ-f). The questionnaire contains eight items measuring observed cognitive difficulties in daily life, with responses provided on a five-point scale from never to always. The instrument has been translated and culturally adapted for Swedish use by our research group following back-translation procedures. The recall period was shortened from six months in the original version to one month to better reflect the postoperative recovery trajectory.

    Time frame: Preoperatively, 1 month, 3 months and 6 months

  12. Caregiver burden

    Zarit Burden Interview, 12-item version (ZBI-12). The instrument contains 12 items, each rated on a five-point Likert scale ranging from never to nearly always.

    Time frame: Preoperatively, 1 month, 3 months and 6 months

  13. Plasma osmolality

    Osmolality will be estimated using the blood-based biomarkers sodium, glucose, and urea and calculated according to the following formula: Osmolarity (mOsm/L) = 2 × Sodium (mmol/L) + Glucose (mg/dL) / 18 + Urea (mg/dL) / 2.8.

    Time frame: Preoperatively and postoperative day 1

  14. Cost-utility

    Will be assessed by calculating quality-adjusted life years (QALYs) gained using data obtained from the RAND-36.

    Time frame: Through 6 months

Other outcomes

  1. Demographic and perioperative data

    Will be collected from the medical record.

    Time frame: At baseline and perioperatively

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Dec 2027, 11 months later.

Of 63 non-industry interventional studies with no phase under Postoperative Cognitive Complications, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 33. This study's planned 11 months is below that.

Counting every sponsor, half of 63 studies reached it within 16 months; a quarter within 8 and three quarters within 33.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 13, 2026
First posted
Nov 19, 2026
StartEst.
Jan 2027
Primary completionEst.
Dec 2027
CompletionEst.
Dec 2027
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07947784
Responsible party
Ulrica Nilsson (Professor, Principal Investigator, Karolinska Institutet) — Principal investigator
First posted
Nov 19, 2026
Start date
Jan 2027 (estimated)
Primary completion
Dec 2027 (estimated)
Completion
Dec 2027 (estimated)
Last update
Nov 19, 2026

Study contacts

Lina Bergman, PhD
Contact
lina.bergman@hb.se
0046 33 435 44 11
Ulrica Nilsson, Professor
Contact
ulica.nilsson@ki.se

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion